Literature DB >> 15212685

IFN-gamma-mediated inhibition of COX-2 expression in the placenta from term and preterm labor pregnancies.

Nazeeh Hanna1, Lea Bonifacio, Pradeep Reddy, Iman Hanna, Barry Weinberger, Shaun Murphy, Debra Laskin, Surendra Sharma.   

Abstract

PROBLEM: The inflammatory-anti-inflammatory cytokine network is thought to play a critical role in regulated progression and termination of pregnancy. The aim of this study was to evaluate the effects of interferon (IFN)-gamma on the expression of Cyclooxygenase (COX)-2 and production of prostaglandin E(2) (PGE(2)) in the human placenta from term and preterm labor deliveries. METHOD OF STUDY: Placental explant culture system was used. COX-2 expression was determined by complementary techniques of immunohistochemistry and Western blotting. Released IFN-gamma and PGE(2) by placental explants were measured by enzyme-linked immunosorbent assay. Signal transducer and activator of transcription 1 (STAT1) phosphorylation was evaluated by Western blotting using a specific antibody.
RESULTS: IFN-gamma was poorly detected in the placenta but was significantly expressed in decidual tissues from both term and preterm pregnancies as detected by immunohistochemistry. IFN-gamma significantly inhibited COX-2 expression and PGE(2) release in cultured placental explants from term and preterm labor deliveries. This effect most likely occurred in a STAT1-dependent manner as this regulatory protein was phosphorylated in response to IFN-gamma. IFN-gamma receptor (IFN-gammaR) was expressed in normal early pregnancy placental samples. However, its expression was significantly reduced in placental samples from term and preterm deliveries. Of interest, IFN-gammaR was expressed in placentas from term and preterm labor deliveries after 24 hr in culture.
CONCLUSIONS: Our data suggest that the human placenta is an important site for IFN-gamma-mediated repression of COX-2 expression and PGE2 production, implying that functional withdrawal of IFN-gamma may be involved in the onset of term or preterm labor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212685     DOI: 10.1111/j.1600-0897.2004.00162.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  12 in total

1.  Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Authors:  Andrea Gray; Rene S Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2016-09

2.  Polybrominated diphenyl ethers enhance the production of proinflammatory cytokines by the placenta.

Authors:  M R Peltier; N G Klimova; Y Arita; E M Gurzenda; A Murthy; K Chawala; V Lerner; J Richardson; N Hanna
Journal:  Placenta       Date:  2012-06-30       Impact factor: 3.481

Review 3.  Gestational tissue inflammatory biomarkers at term labor: A systematic review of literature.

Authors:  Emily E Hadley; Lauren S Richardson; Maria R Torloni; Ramkumar Menon
Journal:  Am J Reprod Immunol       Date:  2017-10-27       Impact factor: 3.886

Review 4.  Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.

Authors:  John W Steinke; Spencer C Payne; Larry Borish
Journal:  Immunol Allergy Clin North Am       Date:  2016-09-13       Impact factor: 3.479

5.  Chronic infection during placental malaria is associated with up-regulation of cycloxygenase-2.

Authors:  Demba Sarr; Delphine Aldebert; Laurence Marrama; Emilie Frealle; Alioune Gaye; Hamoud O Brahim; Makhtar Niang; Jean Marie Dangou; Odile Mercereau-Puijalon; Jean Yves Lehesran; Ronan Jambou
Journal:  Malar J       Date:  2010-02-09       Impact factor: 2.979

Review 6.  Interferon gamma in successful pregnancies.

Authors:  Shawn P Murphy; Chandrakant Tayade; Ali A Ashkar; Kota Hatta; Jianhong Zhang; B Anne Croy
Journal:  Biol Reprod       Date:  2009-01-21       Impact factor: 4.285

Review 7.  TLR-mediated preterm birth in response to pathogenic agents.

Authors:  Jessica E Thaxton; Tania A Nevers; Surendra Sharma
Journal:  Infect Dis Obstet Gynecol       Date:  2010-08-23

8.  Type 2 and type 3 innate lymphoid cells at the maternal-fetal interface: implications in preterm birth.

Authors:  João Mendes; Paulo Rodrigues-Santos; Ana Luísa Areia; Jani-Sofia Almeida; Vera Alves; Manuel Santos-Rosa; Anabela Mota-Pinto
Journal:  BMC Immunol       Date:  2021-05-06       Impact factor: 3.615

9.  Literature-Informed Analysis of a Genome-Wide Association Study of Gestational Age in Norwegian Women and Children Suggests Involvement of Inflammatory Pathways.

Authors:  Jonas Bacelis; Julius Juodakis; Verena Sengpiel; Ge Zhang; Ronny Myhre; Louis J Muglia; Staffan Nilsson; Bo Jacobsson
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

10.  Differential outcomes of TLR2 engagement in inflammation-induced preterm birth.

Authors:  Monica Cappelletti; Matthew J Lawson; Calvin C Chan; Adrienne N Wilburn; Senad Divanovic
Journal:  J Leukoc Biol       Date:  2017-12-28       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.